CAMPBELL, CALIFORNIA, OCTOBER 22nd 2013– Creganna-Tactx Medical, a global Top 10 provider of medical device outsourcing solutions, will showcase the expertise of its California Center of Excellence for Emerging Therapies at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco, California.
Campbell, California, Center of Excellence for Emerging Therapies. Supporting customers to accelerate time to market for breakthrough medical therapies. (Image credit: Kurzweil & University of Illinois, Chicago)
The largest provider of outsourced product design & development solutions on the West Coast, the company’s California facility is the partner of choice for medical device companies developing breakthrough products for emerging minimally invasive therapies. A single-site solution, the Campbell Center of Excellence provides all of the services and expertise to deliver an approved medical device to market on behalf of its customers.
“Emerging therapies hold enormous commercial potential for our customers” explains David O’Keeffe, Global VP of Sales & Marketing at Creganna-Tactx Medical. “For example, the global Transcatheter Aortic Valve Replacement (TAVR) market is estimated to reach more than $1.5bn by 2015. Over 40 companies are developing novel therapies for the potential $2bn renal denervation market, while next generation technologies such as bioabsorbable stents are forecast to triple yearly growth for the next 5 years.”
“The potential rewards are significant, but developing new categories of devices for emerging therapies is a highly challenging process. Our customers are breaking new ground. Choosing a knowledgeable commercialization partner with specialist insight accelerates that journey to market. Our Campbell team has played a remarkable role in partnering with pioneering companies to get these highly complex products into the hands of physicians faster and more efficiently.”
To celebrate the achievements of the Campbell Center of Excellence, an informal gathering of customers and those involved in device innovation throughout the Bay area will be held during TCT 2013. New company CEO, Chip Hance, will host the evening along with the company’s previous CEO, Chairman, Management & Campbell site team for a meet and greet event. To register for the event on Wednesday, October 30th please visit www.cregannaevents.com
Creganna-Tactx Medical will be exhibiting at TCT October 29th – 31st at booth # 1132.
About Creganna-Tactx Medical
Creganna-Tactx Medical is ranked among the Top 10 global companies in the medical device outsourcing industry. The company specializes in the design and manufacture of minimally invasive access & delivery devices for a range of therapies. Serving over 400 companies across 30 countries, customers include the world’s leading medical device and lifescience companies. Headquartered in Galway, Ireland, Creganna-Tactx Medical has an extensive global footprint with design and manufacturing facilities spanning the US, Europe and Asia. www.creganna.com
As the global evolution towards minimally invasive surgery accelerates, Creganna-Tactx Medical remains at the forefront of pioneering medical technologies, partnering with the world’s leading medical companies to deliver breakthrough products to market together.
Media Contact:
Maura Leahy
Creganna-Tactx Medical
Parkmore West, Galway, Ireland
Tel direct: +353 91 757801
Email: maura.leahy@creganna.com